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Abstract
Background: The COVID-19 pandemic is spreading all over 
the world, particularly in developed countries where obesity 
is also widespread. There is a high frequency of increased 
BMI in patients admitted to intensive care for SARS-CoV-2 
infection with a major severity in patients with an excess of 
visceral adiposity. Patients at risk of severe SARS-CoV-2 acute 
respiratory syndrome are characterised by the high preva-
lence of pre-existing diseases (high blood pressure and car-
diovascular disease, diabetes, chronic respiratory disease, or 
cancer), most of them typically present in severely obese pa-
tients. Indeed, the biological role of adipose tissue in sustain-
ing SARS-CoV-2 infection is not completely elucidated. Sum-
mary: The forced isolation due to pandemic containment 
measures abruptly interrupted the rehabilitation programs 
to which many patients with severe obesity were enrolled. 
People affected by obesity, and especially those with severe 
obesity, should continue clinical rehabilitation programs, 
taking extra measures to avoid COVID-19 infection and rein-
forcing the adoption of preventive procedures. In this re-
view, the available data on obesity and COVID-19 are dis-
cussed along with evidence-based strategies for maintain-
ing the necessary continuous rehabilitation programs. Key 
Messages: Greater attention is needed for obese and severe-
ly obese patients in the face of the current COVID-19 pan-
demic, which represents a huge challenge for both patients 
and healthcare professionals. The adoption of new strate-
gies to guarantee adequate and continuous multidisci-
plinary nutritional rehabilitation programs will be crucial to 
control the severity of SARS-CoV-2 infection in high-risk pop-
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ulations as well as the worsening of obesity-linked complica-
tions. Health authorities should be urged to equip hospitals 
with tools for the diffusion of telemedicine to maintain phy-
sician-patient communication, which is fundamental in 
chronic and complicated obese patients.
© 2021 The Author(s)
Published by S. Karger AG, Basel
Introduction
Obesity is considered a chronic disease state [1] and 
currently the major strategy to take action regarding the 
management of obese patients, particularly metabolically 
unhealthy patients with a body mass index above 40, is to 
plan long-term rehabilitation programs. Various evi-
dence exists for the benefit of providing continuous mul-
tidisciplinary (dietary, psychological, motor/functional) 
supportive programs to counteract the degenerative ef-
fects of chronic obesity, especially for patients not eligible 
to the available drug therapies or eligible for bariatric sur-
gery procedures.
In December 2019, the novel coronavirus (SARS-
CoV-2) pneumonia emerged in Wuhan (China), with 
cases rapidly increasing worldwide. On March 11, 2020 
the World Health Organisation declared the COVID-19 
infection a pandemic. In Europe, Italy was certainly one 
of the first and most affected countries. From March 10 
to May 4, 2020 the Italian Government implemented re-
strictive measures to contain the infection spread. The 
containment measures consisted of a temporary closure 
of all non-essential activities, strengthening the measures 
aimed to increase personal hygiene, symptom monitor-
ing, early diagnosis, and patient isolation. Indeed, all non-
urgent medical visits, including clinical practices planned 
for obesity management, were deferred to ensure social 
distancing [2] and reduce the virus spread. During this 
period, a worsening of clinical/functional complaints and 
nutritional and metabolic status was observed in obese 
patients due to changes in lifestyle habits and reduction 
in exercise practice [3]. Many people became stressed and 
depressed as a result of overexposure to news about the 
spread of COVID-19 and the “forced” social isolation, 
which led to an increased incidence of eating disorders, 
resulting in weight gain [4]. Moreover, patients with se-
vere obesity and those with previous bariatric surgery 
represent a vulnerable cohort of patients with an in-
creased risk of infection and/or a severe course of CO-
VID-19 [5]. Thus, in response to a possible “phase 2” of 
the COVID-19 pandemic, and in general to facilitate all 
those patients who do not have easy access to a long-term 
rehabilitation program for different reasons (motor dis-
ability, residence in a remote area, etc.), it is necessary to 
encourage innovative strategies for obesity management 
to avoid nosocomial dissemination of the virus and, at the 
same time, maintain standard follow-up for patients who 
require continuous rehabilitative support. Here, we ana-
lysed the main negative effects of the COVID-19 pan-
demic on dietary habits, eating behaviour, and physical 
activity in severely obese patients, discussing new strate-
gies that could be put into place to counteract them in the 
future.
Adipose Tissue and Infection Susceptibilities
Patients with obesity and morbid obesity have a known 
increased susceptibility to viral infections [6]. The excess 
of white adipose tissue and the “low-grade” chronic pro-
inflammatory state that characterises obesity are proba-
bly the biological basis for a dysregulated immune re-
sponse as well as for the development of metabolic com-
plications, such as insulin resistance and type 2 diabetes 
[7]. Adipose tissue is effectively at the interface between 
metabolism and immunity [8, 9], and immune system 
cells and adipocytes share numerous similarities in struc-
ture and functions, especially in the production of some 
inflammatory mediators [10]. It is well documented that 
obese patients have a more intense interleukin-8 release 
in H1N1 infection as compared with normal-weight in-
dividuals [11], and an impaired immune response to in-
fluenza vaccination was also described for obese patients 
[12]. In addition to flu viruses, also the human immuno-
deficiency virus (HIV) has been described in the litera-
ture as an example of a virus capable of interacting with 
white adipose tissue/adipocytes. HIV evades the immune 
system by stopping its replication and persisting in latent 
form in CD4+ T cells and in macrophages. Infected im-
mune cells allow the virus to migrate into non-lymphoid 
tissues, including white adipose tissue, where it could re-
main latent or resumes its replication. HIV viral replica-
tion can also take place in the white adipose tissue [13] 
and the adipocyte is a target for HIV infection since it 
carries on its surface the receptors essential for viral entry 
(CD4, CXCR4, and CCR5) [13, 14]. Concerning the 
pathogenesis of SARS-CoV-2 infection, it is almost clear 
that the viral entry includes the recognition of angioten-
sin-converting enzyme 2 receptor (ACE2) by the virus 
spike protein and by the cellular transmembrane protease 
serine 2 (TMPRSS2) helping host cell viral entry and 
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spread. ACE2 receptors are widely distributed in various 
organs and cell types, including adipose tissue in which 
the expression levels reported are higher than in lung tis-
sue [15]. Obese individuals, having an increased adipose 
mass in the body, possibly increase the number of ACE2-
expressing cells, resulting in major infection susceptibil-
ity. Recently, a role for human dipeptidyl peptidase 4 
(DPP4) was also suggested for SARS-CoV-2 infection. 
DPP4 expression is higher in visceral adipose tissue and 
directly correlates with adipocyte inflammation and insu-
lin resistance [16]. Interestingly, the 3 cytokines recently 
described with an exuberant elevation during the SARS-
CoV-2-induced “cytokine storm” (IP-10, also known as 
CXCL-10, MCP-3, and IL-1ra) [17] are also produced 
and secreted by adipocytes and adipose tissue-infiltrating 
immune cells [18] (Fig. 1). Targeted research of SARS-
CoV-2 and its role in human adipose tissue is needed, but 
in the meantime extra preventive measures should be 
provided during this pandemic period for obese and mor-
bidly obese patients, who represent a group of patients 
more fragile and susceptible to infections.
Outpatient Support
Reduction of Direct Exposure
The management of patients with severe obesity and 
those after bariatric surgery is often performed in hospi-
tals engaged as COVID-19 hotspots, thus potentially put-
ting obesity-affected outpatients at risk of nosocomial in-
fections. In addition, to maintain social distancing, fewer 
health services and medical examinations are possible. 
Prioritisation criteria need to be defined for outpatient 
contacts to be guaranteed the greatest number of health 
services in compliance with the local COVID-19 burden 
and officially implemented rules and regulations. Indi-
vidual therapy is the basis for obesity treatment, enables 
physician-patient relationships, and allows physicians to 
quickly assess the overall condition of the patient. How-
ever, due to the number of single contacts, physicians are 
at high risk of infection and consequently also of virus 
dissemination. In order to minimise the risk and to pro-
tect vulnerable patient cohorts from individuals with po-
tential SARS-CoV-2 infection, physical distancing needs 
to be implemented through changes to operating proce-
dures for outpatient care, including remodelling of wait-
ing areas to allow sufficient distance between patients, re-
duction of waiting times, and encouraging changes in the 
routine of clinical practices to limit the amount of face-
to-face contact for patients at risk of a more severe course 
of infection. Technical solutions for individual protection 
are available to enable remote physician-patient interac-
tions and their benefits have already been discussed in the 
context of the COVID-19 pandemic [19]. Group therapy 
has been a proven strategy to support behavioural chang-
es and greater weight loss than an individual approach. 
The program generally consists of weekly group meet-
ings, which include psychologists, dietitians, physiother-
apists, and physicians. They introduce and explain eating 
and exercise-related strategies by using a cognitive-be-
havioural approach [20]. Table 1 presents the main strat-
egies to reduce the risk of virus dissemination the pan-
demic.
Support to Control Eating Behaviour
The link between obesity and stress is well known. 
Stress triggers physiological changes in the hypothalam-
ic-pituitary-adrenal axis, reward processing in the brain, 
and stimulates the production of biochemical hormones 
and peptides such as leptin, ghrelin, and neuropeptide 
involved in the regulation of hunger and satiety [21]. For 
Fig. 1. Inflammatory cytokines upregulated in the “cytokine 
storm” of SARS-CoV-2 induced in lung cells are also produced and 
secreted by adipose tissue, adipocytes, and resident immune cells 
of obese patients, suggesting a potential “addictive” pro-inflamma-
tory effect. Tumour necrosis factor-alpha (TNF-α), interleukin 6 
(IL-6), interferon gamma (INF-γ), INF-γ-induced protein 10 (IP-
10 or CXCL10), monocyte-chemotactic protein 3 (CCL7 or MCP-
3), monocyte-chemotactic protein 1 (CCL2 or MCP-1), and inter-
leukin 1 receptor antagonist (IL-1ra) were associated with an in-
creased viral load, loss of lung function, lung injury, and a fatal 
outcome. This figure was generated with images from Servier 
Medical Art (www.servier.com), licensed under the Creative Com-
mons Attribution 3.0 unported license (http://creativecommons.
org/license/by/3.0/).
De Amicis et al.Obes Facts4
DOI: 10.1159/000513283
these reasons stress leads individuals to eat higher quanti-
ties of food with a higher tendency to prefer palatable 
food, to decrease the tendency for physical activity, and 
to induce shorter periods of sleep, favouring eating disor-
ders. A recent Italian survey reported that during the CO-
VID-19 lockdown, the sense of hunger and satiety 
changed for more than half of the population: more than 
half of interviewees reported an increased appetite. The 
increase in the sense of hunger and the resulting change 
in eating habits could explain the perception of weight 
gain observed [3]. These pathways could include in-
creased risks (such as media exposure, disruption to dai-
ly activities, social isolation, modified physical activity 
and sleep, negative effects, and fear of contagion) and 
lower the protective capacity and access to support pro-
grams (such as social support, emotion regulation, and 
access to clinical treatments), particularly in childhood 
obesity [22]. Moreover, scheduled follow-up visits for 
obese patients stopped during the lockdown, so a massive 
effort to seek new therapeutic strategies is needed.
In order to monitor psychosocial well-being related to 
body image and eating attitudes, technological devices 
could be implemented for obese patients as has been done 
for individuals with subthreshold psychological symp-
toms during the COVID-19 pandemic [23]. As telemedi-
cine is becoming the “new normal” for healthcare provid-
ers, strategies like weekly self-weighing with a bathroom 
scale and other behaviour modifications able to favour 
the maintenance of adequate food intake and dietary 
quality may be adapted by dieticians/nutritionists to pro-
vide virtual counselling and healthy weight management 
practices at home. The time for using virtual strategies/
activities and social networks has never been greater and 
may be used to support healthy behaviour practices [4]. 
For example, telemedicine could lead to the implementa-
tion of mindful eating and a newer concept of intuitive 
eating through modulating eating habits and emotional 
eating in response to external cues [24]. The familiar 
home environment and the absence of external stimuli 
could in fact allow the application of mindfulness-based 
approaches that may prevent weight gain, reducing food 
intake, and working by an increased awareness of inter-
nal, rather than external, cues to eat. Telenutrition sup-
port involves the interactive use, by a nutritionist, of 
Table 1. New strategies for obesity management during the COVID-19 pandemic
Strategies to reduce direct exposure during group therapy
– Limited number of participants
– Adequate space/people ratio (2 m2 each)
– Priority for access to the most clinically urgent obese patients (eating disorders, need for weight loss prior to surgery, type 2 diabetes decompensated)
– No access to patients who are most at risk in the case of SARS-CoV-2 infection (age >70 years, chronic respiratory diseases, oncological diseases in 
the last 12 months, immunosuppression)
– Training patients on the hygiene and health standards to follow during group therapy
– Detection of cases of infection by check points at the entrance of the hospital
– Security distance of at least 1 m apart between patients both in the waiting area and during group therapy
– Sanitising of environments and tools after each use, according to standardised procedures
– Use of individual safety devices
Web-based strategies to control eating behaviour
– Participation in virtual races or activity challenges (e.g., mindful eating, intuitive eating)
– Virtual social support groups
– Web-based healthy meal ideas, cooking tips, and ideas for modifying recipes for pantry items
Strategies to maintain adequate food intake and dietary quality
– Weighing once a week
– Eating vegetables, fruits, and pulses on a daily base
– Limit the intake of free sugars and processed/ultra-processed foods
– Avoid alcoholic drinks
– Prepare a shopping list and a cooking plan
– Follow-up by implementation of telenutrition
Strategies to maintain physical activity
– Exercise at home (or outside but in respect of safety measures) on a daily base, to counteract sedentary behaviours
– Alternation of combined physical activity or concurrent training (a mix of aerobic and rehabilitative exercise on the same day)
– Follow-up by new communication technologies
Rehabilitation Program for Severely 
Obese Patients during COVID-19
5Obes Facts
DOI: 10.1159/000513283
email or mobile phone text messaging, smartphone ap-
plications (apps) or interactive web conferencing to im-
plement the nutrition care process (nutrition assessment, 
diagnosis, intervention/plan of care, and monitoring and 
evaluation) with patients at a remote location, within the 
provisions of their state licensure as applicable [25–27]. 
So, the physician can verify the subject’s adherence to diet 
and exercise, recommend therapeutic adjustments, and 
provide a set of strategies to promote alternative behav-
iours during critical situations or negative mood states. 
Moreover, telenutrition leads patients to follow the social 
pages of nutritional science that offer nutritional advice 
and nutritional news in simple language. Online support 
groups can be helpful in maintaining motivation and mit-
igating stress, especially in patients with eating disorders. 
It might be a useful tip to motivate daily change and ex-
ploit the sense of group and peer imitation, providing ad-
vice and exchanging recipes and experiences, besides 
helping patients to recognise official social pages and lim-
it exposure to fake news. Web-based supporting technol-
ogies useful to counteract eating behaviour changes are 
summarised in Table 1.
Support to Maintain Food Intake and Dietary Quality
Maintaining adequate food intake for severely obese 
people is hard in normal times, but becomes a huge chal-
lenge during extraordinary events, such as the recent CO-
VID-19 pandemic [28]. The fear of food shortages and 
the need to stock up led individuals to buy large quantities 
of food and to consequently eat more, together with an 
increased tendency for storing canned and ultra-pro-
cessed products due to their secure storage and prepara-
tion, as well as the probability of eating while doing other 
activities. Ultra-processed foods are well known to have a 
high content of refined carbohydrates, which can lead to 
a change in insulin response, causing excess nutrient stor-
age in adipose tissue [29], and may affect the brain reward 
system by leading to addictive-like behaviours and over-
consumption.
The boredom, the economic strain, and the continu-
ously hearing or reading about the pandemic could be 
stressful and inevitably cause overeating and looking for 
“comfort foods,” such as sweets. As the COVID-19 pan-
demic continues, the real fear of a decrease in food sup-
plies contributes significantly to increasing the global 
burden of obesity, with decreased activity and stay-at-
home measures. Moreover, as shown by Di Renzo et al. 
[3], adherence to a Mediterranean diet by Italian people 
during the COVID-19 pandemic was low, especially in 
elderly and obese people.
For all these reasons, obese patients need ongoing sup-
port to manage the disease during the pandemic [30]. 
First, we need to remind patients that obesity is a chronic 
disease and that even a slight weight gain can have conse-
quences on comorbidities, such as a worsening of diabe-
tes, hypertension, or sleep apnoea. Thanks to telemedi-
cine, nutritionists, together with physiatrists/psycholo-
gists, could “virtually” enter patients’ homes and maintain 
focus on the daily management of the disease. A virtual 
link could establish a supportive relationship and tailor-
made strategies more oriented to the prevention and 
treatment of the patient, and not only to the treatment of 
the disease. It might be helpful to program daily food rou-
tines, regularly planning 3 meals and 2–3 snacks a day. 
Planning of the weekly cooking plan is crucial to optimise 
time and the need to go out for food purchases. It is im-
portant to give space for creativity and to take advantage 
of the extra time to motivate to cook and to taste new 
foods, encouraging patients in the adoption healthy reci-
pes. Also, planning daily hydration, providing water in 
small sips during the day, but also herbal teas and infu-
sions, to modulate the sense of hunger and satiety could 
be helpful. While nutritional education can benefit from 
a virtual system, the lack of detection of anthropometric 
measures useful in evaluating the effectiveness of the diet 
is on the other hand a limitation of such an application. 
For this reason, physical consultations must be arranged, 
for example by reducing their frequency and alternating 
them with telematic controls. Currently, video support 
has begun, but the effectiveness of this remote support is 
still to be determined by longitudinal and well-monitored 
studies. Table 1 summarise strategies to maintain a cor-
rect food intake and dietary quality.
Support to Maintain Adequate Physical Activity
The SARS-CoV-2 pandemic and the related lockdown 
and social distancing measures have had a tremendous 
impact on the individual level of habitual physical activ-
ity. Isolation has been effective in reducing the spread of 
SARS-CoV-2, but it also represented a severe limitation 
of patient movement, thus magnifying, in symptomatic 
patients, the risk of immobilisation syndromes. Individu-
als with obesity and chronic diseases are at risk of reduced 
skeletal muscle mass and function (sarcopenia) and in-
creased body weight during forced inactivity periods [31]. 
This is a risk for malnutrition conditions with potential 
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negative outcomes in the case of COVID-19 infection 
[32].
Physical activity is to be recommended during 
isolation for several reasons, including psychophysical 
well-being. Most importantly, moderately intense aero-
bic exercise is sufficient to improve immune health 
via enhanced recirculation of immunoglobulins, anti-in-
flammatory cytokines, neutrophils, NK cells, cytotoxic T 
cells, and immature B cells, with improved cellular im-
mune function and metabolic health [33]. Also, high-in-
tensity exercise has shown an anti-inflammatory response 
[34–37]. However, high-intensity interval training (90% 
maximum heart rate, 3 times a week) decreased the 
IFN-γ/IL-4 ratio and increased TNF-α, while moderate-
intensity continuous training (70% maximum heart rate, 
5 times a week) decreased TNF-α in obese adults [38]; 
thus, high-intensity exercise may be dangerous in obesity 
and could help to exacerbate the SARS-CoV-2 virus [39]. 
Several examples of home exercises have been provided 
to the general/elderly population during lockdown. 
Among them, a manual by Ambrose and Verghese [40] 
provided examples of lying, sitting, and standing exer-
cises with the aim of recommending a self-directed exer-
cise program at home which does not require any special 
equipment.
Novel Strategies for Physical Activity and 
Rehabilitation
The European health and care systems are now facing 
multiple challenges, for which new digital technologies 
should become solutions to support their sustainability. 
Inpatient rehabilitation programs have strict inclusion 
criteria and high costs. Rehabilitation programs are large-
ly performed in an outpatient setting. Home-based su-
pervised programs, conversely, are heavy on logistics on 
the provider side. To circumvent this, telerehabilitation 
solutions have been developed and proposed to assist 
health facilities in the management of their services. Such 
solutions would allow physiotherapy to be delivered to a 
greater number of patients, increasing their reach, more 
quickly, and with comparable clinical results, thus im-
proving the scalability of care.
Digital biofeedback systems for home-based physical 
rehabilitation have been available since 2016 and have 
been clinically validated for remote physiotherapy, dem-
onstrating that a digital rehabilitation solution can reduce 
the dependence on human resources while ensuring bet-
ter clinical outcomes than conventional rehabilitation, 
providing objective data for decision-making, but also 
working in tandem with clinical teams to ensure not only 
the scalability of care, but also enabling an exponential 
increase in the active caseload per clinician. A person-
alised treatment service can be offered through an app 
providing individualised exercises, activity advice, infor-
mation, and coaching. The system can retrieve the actual 
movement data, as provided by motion sensors, as well as 
processed data, such as the number of correct move-
ments, the reasons behind any wrong movements, and 
the reported pain and fatigue. An artificial Intelligence 
engine could check the patient’s session data and deter-
mine, according to the latter, which changes to that pa-
tient’s prescription are required to maximise the quality 
and efficiency of the therapy. The personalisation of the 
treatment is based on the patient’s progress through the 
rehabilitation, by the feedback gathered through daily re-
porting, as well as a smart wearable band that captures the 
individual activity profile. The advantages of such tech-
nological solutions for rehabilitation are: (a) not requir-
ing patients to physically be in the health facility to receive 
physiotherapy, and (b) they can be integrated with a 
health facility’s electronic health record, thus filling the 
gap between in- and outpatient discontinuity. Moreover, 
the health system is currently subject to very high pres-
sure and the role of telemedicine could be fundamental to 
increase the resilience of the system itself. This system is 
certainly not free from limitations, especially for older 
people, who might not be familiar with the use of digital 
tools or have availability of the digital tool itself, especial-
ly for those with a low income or socioeconomic status. 
Clearly telehealth will not replace physical consultations 
in all scenarios, but it can dramatically streamline quite a 
few scenarios, improving the lives of patients and reduc-
ing overall costs across the system.
Support for Bariatric Patients
Approximately 70% of patients who are candidates for 
bariatric surgery have a personal history of psychiatric 
pathology or psychologic distress, which can be exacer-
bated by the pandemic-induced stress environment be-
fore and after bariatric surgery [41–44].
Bariatric Surgery Candidates
The COVID-19 pandemic has forced the postpone-
ment of many elective surgeries, including bariatric and 
metabolic surgery [41, 45]. Access to bariatric surgery 
procedures will see everything else gradually return to 
normal, and this, in addition to the increase in demand 
due to the temporary interruption of surgery, may lead to 
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a further reduction in the availability/demand ratio of 
surgical need in this clinical setting [41].
With a view to prioritising candidates for bariatric 
procedures, the traditional weight-centric criterion, al-
though still commonly used, does not adequately reflect 
the severity of the disease, and cannot therefore be con-
sidered in relation to current clinical needs [41]. In this 
scenario, a screening for preoperative COVID-19 is man-
datory to identify appropriate criteria to prioritise pa-
tients in a period of limited capacity [41].
Post-Operative Bariatric Patients
Restricting access to non-urgent cases could adversely 
affect the proper monitoring of potential post-operative 
surgical and nutritional complications. It has proved im-
portant to try to avoid the sense of abandonment and iso-
lation that patients often experience during the post-bar-
iatric recovery period to limit the harm during and after 
the COVID-19 pandemic [46]. Telemedicine consulta-
tions, dietary and psychological evaluations in single/
multidisciplinary surgery, always remotely, with the cre-
ation of a social network and online support, may be a 
viable solution to support the post-operative period and 
identify any complications early [45]. Telemedicine strat-
egies supervised by specialised bariatric and metabolic 
surgery centres have been shown to have positive effects 
with regard to weight loss and psychosocial goals, com-
parable to those of in-presence therapy [47]. Remote cog-
nitive behavioural therapy has been shown to be effective 
in improving mood and eating behaviour (anxiety and 
depression, emotional eating, and binge eating) in bariat-
ric patients [48]. This approach could be useful also to 
identify signs and symptoms of potential nutritional de-
ficiencies (decrease in vision, skin rash, easy fatigue, oe-
dema or anasarca, neuropsychiatric signs, nausea, paraes-
thesia, changes in the bowel, asthenia), and to provide for 
the possibility of personal visits in urgent cases that sug-
gest severe biochemical deficiencies or surgical complica-
tions [41, 45].
Conclusion
The COVID-19 pandemic is a huge challenge for both 
obese patients and health professionals, but it can also be 
an opportunity to implement the diffusion of telemedi-
cine and telenutrition to improve the management of 
obesity, a disease in which physician-patient communi-
cation is fundamental and must never be interrupted. 
Health authorities should be urged to equip hospitals 
with such systems not only to attend to COVID-19 pa-
tients who stay in home isolation, but also to care for pa-
tients that need to be protected from a potentially harmful 
infection and guide them through the pandemic, explain-
ing the future treatment/management, strategies/plan, 
and provide advice concerning general prevention mea-
sures. The current pandemic clearly underlines the im-
portance of making these technical solutions available to 
healthcare providers to be better prepared for situations 
like these in the future.
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